Browsing by Author "Nazan Tuna"

Now showing items 1-3 of 3

Hepatitis B reactivation and timing for prophylaxis

Nazan Tuna; Karabay, Oğuz (BAISHIDENG PUBLISHING GROUP INC, 2015)

It is known that immunotherapy and cancer chemotherapy may cause hepatitis B virus (HBV) reactivation in hepatitis B surface antigen carriers and inactive chronic hepatitis B patients. Guidelines recommend antiviral ...
Predictors of Pegylated Interferone Treatment Response In HBeAg Negative Chronic Hepatitis B

Güçlü, Ertuğrul; Nazan Tuna; Karabay, Oğuz (WILEY-BLACKWELL, 2012)
Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B

Güçlü, Ertuğrul; Nazan Tuna; Karabay, Oğuz; Sila Akhan; Hurrem Bodur; Bahadir Ceylan; Tuna Demirdal; Kutbettin Demirdag; Nese Demirturk; Ekerbiçer, Hasan Çetin; Serpil Erol; Esen, Sinan; Omer Evirgen; Mehmet Faruk Geyik; Alper Gunduz; Mustafa Kasim Karahocagil; Omer Faruk Kokoglu; Davut Ozdemir; Nail Ozgunes; Fatma Sargin; Selma Tosun; Ediz Tutuncu (J INFECTION DEVELOPING COUNTRIES, 2014)

Introduction: Although pegylated interferons (pegIFNs) alpha-2a and alpha-2b have been used in chronic hepatitis B (CHB) treatment for many years, there are few studies concerning predictors of sustained virologic response ...